RU93044256A - METHOD OF TREATING SARKOIDOSE - Google Patents

METHOD OF TREATING SARKOIDOSE

Info

Publication number
RU93044256A
RU93044256A RU93044256/14A RU93044256A RU93044256A RU 93044256 A RU93044256 A RU 93044256A RU 93044256/14 A RU93044256/14 A RU 93044256/14A RU 93044256 A RU93044256 A RU 93044256A RU 93044256 A RU93044256 A RU 93044256A
Authority
RU
Russia
Prior art keywords
treating
sarkoidose
olifen
drug
olyphenotherapy
Prior art date
Application number
RU93044256/14A
Other languages
Russian (ru)
Other versions
RU2082397C1 (en
Inventor
Л.А. Хоровская
З.И. Костина
Ю.В. Медведев
Original Assignee
Акционерное общество закрытого типа - Научно-производственная компания "Олифен"
Filing date
Publication date
Application filed by Акционерное общество закрытого типа - Научно-производственная компания "Олифен" filed Critical Акционерное общество закрытого типа - Научно-производственная компания "Олифен"
Priority to RU93044256A priority Critical patent/RU2082397C1/en
Priority claimed from RU93044256A external-priority patent/RU2082397C1/en
Publication of RU93044256A publication Critical patent/RU93044256A/en
Application granted granted Critical
Publication of RU2082397C1 publication Critical patent/RU2082397C1/en

Links

Claims (1)

Способ лечения саркоидоза на основе гормонотерапии с использованием антиоксидантов - препарата "Олифен"- позволяет сократить сроки лечения в 2-4 раза при более высокой эффективности и резком сокращении негативных побочных эффектов. Препарат "Олифен" вводят в течение 1-3 месяцев в суточной дозе 1,5-4,0 г перорально, внутривенно или аэрозольно. Высокую эффективность показало сочетание разных форм олифенотерапии.A method of treating sarcoidosis based on hormone therapy with the use of antioxidants, the drug Olifen, reduces the treatment time by 2-4 times with higher efficiency and a sharp reduction in negative side effects. The drug "Olifen" is administered for 1-3 months at a daily dose of 1.5-4.0 g orally, intravenously or by aerosol. High efficiency was shown by the combination of different forms of olyphenotherapy.
RU93044256A 1993-09-08 1993-09-08 Method to treat sarcoidosis RU2082397C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93044256A RU2082397C1 (en) 1993-09-08 1993-09-08 Method to treat sarcoidosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93044256A RU2082397C1 (en) 1993-09-08 1993-09-08 Method to treat sarcoidosis

Publications (2)

Publication Number Publication Date
RU93044256A true RU93044256A (en) 1996-06-10
RU2082397C1 RU2082397C1 (en) 1997-06-27

Family

ID=20147325

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93044256A RU2082397C1 (en) 1993-09-08 1993-09-08 Method to treat sarcoidosis

Country Status (1)

Country Link
RU (1) RU2082397C1 (en)

Similar Documents

Publication Publication Date Title
MY106528A (en) Method of treating impotence.
GEP20002146B (en) Therapeutic Peptide Derivatives
TR199801180T2 (en) New compounds with analgesic effect.
CA2213339A1 (en) Method of treating adenosine depletion
IE893840L (en) Use of acetyl d-carnitines for treating glaucoma
DK0668763T3 (en) Use of Phenserin in the manufacture of drugs for the treatment of cognitive disorders
NO922936D0 (en) PREPARATION OF FATIC ACID MEDICINES
CA2150185A1 (en) Pharmaceutical composition for the treatment of stoma-peripheral inflammation
DE69424777D1 (en) 3,4-DIARYLCHROMANE FOR TREATING DERMATITIS
RU94002133A (en) 6-CHLOR-5-FTOR-3- (2-TENOIL) -2-OXINDOL-1-CARBOXAMIDE AS AN ANALOGESIC AND ANIMATERATIVE MEDICATION
EP0362847A3 (en) The use of etoperidone for preparing a pharmaceutical composition for treating male impotence
CA2108330A1 (en) Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin
TR199801184T2 (en) New compounds with analgesic action.
JPS6483020A (en) Medicinal composition for preventing or treating aids
RU93044256A (en) METHOD OF TREATING SARKOIDOSE
ATE204476T1 (en) USE OF 3,5-DIAMINO-6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZI E TO PRODUCE A MEDICATION FOR THE TREATMENT OF CERTAIN PAIN AND EDEMA
RU95112520A (en) APPLICATION 4'-IODO-4'-DEOXIDOXORUBICINE FOR THE TREATMENT OF AMYLOIDOSIS, METHOD OF TREATMENT OF AMYLOIDOSIS
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
RU96124000A (en) METHOD FOR TREATING PHYSIOGENIC ASTHENIA
RU97101420A (en) METHOD FOR TONZILLITIS TREATMENT
RU96114373A (en) METHOD FOR TREATING EASY COURSE OF ACUTE PNEUMONIA
RU98109810A (en) METHOD FOR PREVENTION AND TREATMENT OF ATHEROSCLEROSIS
GEP20012531B (en) Pharmaceutical Composition with Naaladase Inhibitors for Treating Glutamate Abnormality and Effecting Neuronal Activity in Animals
RU97117735A (en) METHOD FOR TREATING DIPHTERIA
RU93058154A (en) METHOD FOR TREATING EARLY ACQUIRED FORMS OF SYPHILIS